Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease.

Heitzer, Thomas

Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease. [electronic resource] - Circulation Aug 2003 - 536-41 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1524-4539

10.1161/01.CIR.0000081774.31064.62 doi


Acetylcholine--pharmacology
Biological Availability
Blood Flow Velocity--drug effects
Blood Platelets--drug effects
Coronary Artery Disease--drug therapy
Endothelium, Vascular--drug effects
Enzyme Inhibitors--pharmacology
Eptifibatide
Forearm--blood supply
Humans
Male
Middle Aged
Nitric Oxide--metabolism
Nitric Oxide Donors--pharmacology
Peptides--pharmacology
Platelet Aggregation Inhibitors--pharmacology
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Plethysmography
Tirofiban
Tyrosine--analogs & derivatives
Vasodilation--drug effects
Vasodilator Agents--pharmacology
Vasomotor System--drug effects
omega-N-Methylarginine--pharmacology